 Lumos Pharma, Inc. NASDAQ:LUMO Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Lisa Miller - Senior Director, IR Richard Hawkins - CEO Chairman John McKew - Chief Scientific Officer President David Karpf - Chief Medical Officer Lori Lawley - CFO Principal Accounting Officer Conference Call Participants Avraham Novick - Cantor Fitzgerald Co. Yasmeen Rahimi - Piper Sandler Co. Catherine Novack - JonesTrading Institutional Services Edward White - H.C. Wainwright Co. Operator Good afternoon, and welcome to Lumos Pharmas First Quarter 2022 Results Clinical Update Conference Call. 